HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+9.36%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$3.04B
AUM Growth
+$3.04B
(+7.7%)
Cap. Flow
+$88M
Cap. Flow
% of AUM
2.89%
Top 10 Holdings %
Top 10 Hldgs %
52.11%
Holding
62
New
17
Increased
15
Reduced
10
Closed
16
Top Buys
| 1 |
HCA Healthcare
HCA
|
$123M |
| 2 |
Thermo Fisher Scientific
TMO
|
$114M |
| 3 |
Quest Diagnostics
DGX
|
$110M |
| 4 |
Elevance Health
ELV
|
$96.7M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$60.4M |
Top Sells
| 1 |
Dentsply Sirona
XRAY
|
$145M |
| 2 |
Pediatrix Medical
MD
|
$76.9M |
| 3 |
Agilent Technologies
A
|
$70.5M |
| 4 |
AbbVie
ABBV
|
$54.3M |
| 5 |
IQVIA
IQV
|
$54.1M |
Sector Composition
| 1 | Healthcare | 90.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$210B
| $254M | 8.06% | 4,184,160 +526,340 | +14% | +$31.9M |
|
2
Regeneron Pharmaceuticals
REGN
$61.5B
| $216M | 6.85% | 625,000 | – | – |
|
3
Zimmer Biomet
ZBH
$21B
| $215M | 6.81% | 1,925,000 -400,000 | -17% | -$44.6M |
|
4
Labcorp
LH
$23.1B
| $162M | 5.13% | 900,000 -150,000 | -14% | -$26.9M |
|
|
5
Elevance Health
ELV
$71.8B
| $161M | 5.1% | 675,000 +406,230 | +151% | +$96.7M |
|
6
Baxter International
BAX
$12.7B
| $133M | 4.22% | 1,800,000 -324,670 | -15% | -$24M |
|
|
7
HCA Healthcare
HCA
$94.5B
| $123M | 3.91% | +1,200,000 | New | +$123M |
|
|
8
Thermo Fisher Scientific
TMO
$186B
| $114M | 3.62% | +550,000 | New | +$114M |
|
|
9
Quest Diagnostics
DGX
$20.3B
| $110M | 3.48% | +997,580 | New | +$110M |
|
10
UnitedHealth
UNH
$281B
| $99.8M | 3.17% | 406,900 -213,580 | -34% | -$52.4M |
|
11
Pacira BioSciences
PCRX
$1.2B
| $91.5M | 2.91% | 2,855,213 +555,213 | +24% | +$17.8M |
|
|
AERI
12
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $88.8M | 2.82% | 1,314,290 +114,290 | +10% | +$7.72M |
|
13
Intuitive Surgical
ISRG
$170B
| $84.2M | 2.67% | 176,010 -106,410 | -38% | -$50.9M |
|
14
LivaNova
LIVN
$3.08B
| $79.9M | 2.54% | 800,000 -275,000 | -26% | -$27.5M |
|
15
Neurocrine Biosciences
NBIX
$13.8B
| $78M | 2.48% | 793,955 +102,360 | +15% | +$10.1M |
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $75.7M | 2.4% | 952,670 +271,640 | +40% | +$21.6M |
|
17
Masimo
MASI
$7.59B
| $72.9M | 2.32% | 747,040 +172,040 | +30% | +$16.8M |
|
18
Medtronic
MDT
$119B
| $64M | 2.03% | 747,270 +628,150 | +527% | +$53.8M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $60.4M | 1.92% | +486,300 | New | +$60.4M |
|
|
RDUS
20
DELISTED
Radius Health, Inc.
RDUS
| $59.7M | 1.89% | 2,025,000 +125,000 | +7% | +$3.68M |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $58.7M | 1.86% | 345,550 +195,760 | +131% | +$33.3M |
|
22
DexCom
DXCM
$29.5B
| $58.4M | 1.85% | +614,630 | New | +$58.4M |
|
23
Madrigal Pharmaceuticals
MDGL
$9.76B
| $55.2M | 1.75% | +197,281 | New | +$55.2M |
|
24
Qiagen
QGEN
$10.1B
| $52.2M | 1.66% | 1,442,900 -563,940 | -28% | -$20.4M |
|
25
Danaher
DHR
$147B
| $50.2M | 1.59% | 508,330 -59,630 | -10% | -$5.88M |
|